USFDA Approves Granules Pharmaceuticals’ Generic Vyvanse Chewables
Granules Pharmaceuticals, Inc. has successfully received USFDA approval for its bioequivalent generic version of Lisdexamfetamine Dimesylate Chewable Tablets…
USFDA
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide
Potential first and only DHE autoinjector for tough-to-treat migraines and cluster headaches Exenatide approval highlights Amneal’s capabilities in…
Indoco Remedies receives final ANDA approval from USFDA for Varenicline Tablets, 0.5 mg and 1 mg
Indoco Remedies Ltd. announced the final approval of the Company’s Abbreviated NewDrug Application (ANDA) for Varenicline Tablets, 0.5…